Ginlix AI

Analysis of Overbought Consumer Discretionary Stocks ROST and CTRN

#consumer_discretionary #overbought_stocks #RSI_analysis #earnings_watch #market_volatility
Mixed
US Stock
November 26, 2025
Analysis of Overbought Consumer Discretionary Stocks ROST and CTRN

Related Stocks

ROST
--
ROST
--
CTRN
--
CTRN
--
Integrated Analysis

This analysis is based on the Benzinga report [1] highlighting ROST and CTRN as overbought with RSI values of 80.5 and77.3 respectively (above 70 threshold). Recent price gains: ROST +9.57% in 5 days, CTRN +12.28% in5 days [0]. The consumer cyclical sector rose1.228% on Nov25 (third best performer) [2]. ROST has a P/E ratio of27.33x, consensus target of$180 (2% upside), and8.5% sell ratings [0]. CTRN has negative P/E (-21.8x), net profit margin (-2.13%), consensus target of$24 (-46.9% downside), and50% buy ratings [0]. CTRN is set to announce earnings on Dec2 [3].

Key Insights

Cross-domain correlations: Both stocks are in the outperforming consumer cyclical sector but have contrasting fundamentals—ROST with positive earnings vs CTRN with negative metrics. CTRN shows conflicting analyst signals (50% buys vs significant downside target).

Risks & Opportunities

The analysis reveals several risk factors: Overbought conditions (RSI>70) signal potential short-term correction [1]. CTRN faces liquidity concerns (0.43 quick ratio) and earnings volatility on Dec2 [3]. ROST’s high P/E (27.33x) may limit upside [0]. No significant opportunities are identified in the current data.

Key Information Summary

ROST and CTRN are overbought with recent strong gains. ROST has solid fundamentals but some sell ratings; CTRN has negative earnings and conflicting analyst consensus. CTRN’s Dec2 earnings announcement is a critical upcoming event. Both stocks carry short-term correction risk due to overbought RSI values.

Ask based on this news for deep analysis...
Deep Research
Auto Accept Plan

Insights are generated using AI models and historical data for informational purposes only. They do not constitute investment advice or recommendations. Past performance is not indicative of future results.